Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isracann Biosciences Inc ISCNF

Cannabis
Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.


GREY:ISCNF - Post by User

Isracann Biosciences Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(36)
•••
Post by ProfPennyPinchon Mar 26, 2021 3:09pm
154 Views
Post# 32887832

Isracann Biosciences - Israeli Cannabis

Isracann Biosciences - Israeli Cannabis
Isracann Biosciences is ripping up 7.14% today. They recently announced an LOI with an Israeli manufacturer and importation of high quality Canadian cannabis. Additionally, $IPOT is preparing to grow cannabis in their own Israeli facility. 
 
A study conducted by BDS Analytics estimated that global cannabis sales are set to grow from $21.3B in 2020 to $55.9B in 2026. (Annual sales growth of 17% globally). 
 
$IPOT is well positioned to capitalize on this growth as they will not only be able to distribute to the Israeli market but to the massive EU market as well. The March 7th reopening of Israel is also aimed to create a retail resurgence to help the economy recover and cannabis is included in this retail resurgence. IMO it’s a longterm hold and I’m adding more at sub $0.30 levels.
 
(CSE: IPOT) (OTC: ISCNF)
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities